|
1
|
Benson AB, Venook AP, Al-Hawary MM, Azad
N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D,
Garrido-Laguna I, et al: Rectal cancer, version 2.2022, NCCN
clinical practice guidelines in oncology. J Natl Compr Canc Netw.
20:1139–1167. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bahadoer RR, Dijkstra EA, van Etten B,
Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID,
Beets-Tan RGH, Blomqvist LK, et al: Short-course radiotherapy
followed by chemotherapy before total mesorectal excision (TME)
versus preoperative chemoradiotherapy, TME, and optional adjuvant
chemotherapy in locally advanced rectal cancer (RAPIDO): A
randomised, open-label, phase 3 trial. Lancet Oncol. 22:29–42.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bujko K, Nowacki MP, Nasierowska-Guttmejer
A, Michalski W, Bebenek M and Kryj M: Long-term results of a
randomized trial comparing preoperative short-course radiotherapy
with preoperative conventionally fractionated chemoradiation for
rectal cancer. Br J Surg. 93:1215–1223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagasaka M, Zaki M, Kim H, Raza SN, Yoo G,
Lin HS and Sukari A: PD1/PD-L1 inhibition as a potential
radiosensitizer in head and neck squamous cell carcinoma: A case
report. J Immunother Cancer. 4:832016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schoenhals JE, Seyedin SN, Tang C, Cortez
MA, Niknam S, Tsouko E, Chang JY, Hahn SM and Welsh JW: Preclinical
rationale and clinical considerations for radiotherapy plus
immunotherapy: Going beyond local control. Cancer J. 22:130–137.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meng X, Feng R, Yang L, Xing L and Yu J:
The role of radiation oncology in immuno-oncology. Oncologist. 24
(Suppl 1):S42–S52. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Deng W, Li N, Neri S, Sharma A,
Jiang W and Lin SH: Combining immunotherapy and radiotherapy for
cancer treatment: Current challenges and future directions. Front
Pharmacol. 9:1852018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rodriguez-Ruiz ME, Vitale I, Harrington
KJ, Melero I and Galluzzi L: Immunological impact of cell death
signaling driven by radiation on the tumor microenvironment. Nat
Immunol. 21:120–134. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin Z, Cai M, Zhang P, Li G, Liu T, Li X,
Cai K, Nie X, Wang J, Liu J, et al: Phase II, single-arm trial of
preoperative short-course radiotherapy followed by chemotherapy and
camrelizumab in locally advanced rectal cancer. J Immunother
Cancer. 9:e0035542021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
López-Campos F, Martín-Martín M,
Fornell-Pérez R, García-Pérez JC, Die-Trill J, Fuentes-Mateos R,
López-Durán S, Domínguez-Rullán J, Ferreiro R, Riquelme-Oliveira A,
et al: Watch and wait approach in rectal cancer: Current
controversies and future directions. World J Gastroenterol.
26:4218–4239. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guillem JG, Ruby JA, Leibold T, Akhurst
TJ, Yeung HW, Gollub MJ, Ginsberg MS, Shia J, Suriawinata AA,
Riedel ER, et al: Neither FDG-PET Nor CT can distinguish between a
pathological complete response and an incomplete response after
neoadjuvant chemoradiation in locally advanced rectal cancer: A
prospective study. Ann Surg. 258:289–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dayde D, Tanaka I, Jain R, Tai MC and
Taguchi A: Predictive and prognostic molecular biomarkers for
response to neoadjuvant chemoradiation in rectal cancer. Int J Mol
Sci. 18:5732017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamamoto T, Kawada K, Hida K, Matsusue R,
Itatani Y, Mizuno R, Yamaguchi T, Ikai I and Sakai Y: Combination
of lymphocyte count and albumin concentration as a new prognostic
biomarker for rectal cancer. Sci Rep. 11:50272021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheong C, Shin JS and Suh KW: Prognostic
value of changes in serum carcinoembryonic antigen levels for
preoperative chemoradiotherapy response in locally advanced rectal
cancer. World J Gastroenterol. 26:7022–7035. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang CM, Huang MY, Tsai HL, Huang CW, Su
WC, Chang TK, Chen YC, Li CC and Wang JY: Pretreatment
neutrophil-to-lymphocyte ratio associated with tumor recurrence and
survival in patients achieving a pathological complete response
following neoadjuvant chemoradiotherapy for rectal cancer. Cancers
(Basel). 13:45892021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Doi H, Yokoyama H, Beppu N, Fujiwara M,
Harui S, Kakuno A, Yanagi H, Hishikawa Y, Yamanaka N and Kamikonya
N: Neoadjuvant modified short-course radiotherapy followed by
delayed surgery for locally advanced rectal cancer. Cancers
(Basel). 13:41122021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ergen ŞA, Barlas C, Yıldırım C and Öksüz
D: Prognostic role of peripheral neutrophil-lymphocyte ratio (NLR)
and platelet-lymphocyte ratio (PLR) in patients with rectal cancer
undergoing neoadjuvant chemoradiotherapy. J Gastrointest Cancer.
53:151–160. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tjokrowidjaja A, Lord SJ, John T, Lewis
CR, Kok PS, Marschner IC and Lee CK: Pre- and on-treatment lactate
dehydrogenase as a prognostic and predictive biomarker in advanced
non-small cell lung cancer. Cancer. 128:1574–1583. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Petrelli F, Cabiddu M, Coinu A, Borgonovo
K, Ghilardi M, Lonati V and Barni S: Prognostic role of lactate
dehydrogenase in solid tumors: A systematic review and
meta-analysis of 76 studies. Acta Oncol. 54:961–970. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scartozzi M, Giampieri R, Maccaroni E, Del
Prete M, Faloppi L, Bianconi M, Galizia E, Loretelli C, Belvederesi
L, Bittoni A and Cascinu S: Pre-treatment lactate dehydrogenase
levels as predictor of efficacy of first-line bevacizumab-based
therapy in metastatic colorectal cancer patients. Br J Cancer.
106:799–804. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC cancer staging manual. (8th edition).
Springer International Publishing: American Joint Commission on
Cancer; 2017, View Article : Google Scholar
|
|
22
|
Basile D, Garattini SK, Corvaja C, Montico
M, Cortiula F, Pelizzari G, Gerratana L, Audisio M, Lisanti C,
Fanotto V, et al: The MIMIC study: Prognostic role and cutoff
definition of monocyte-to-lymphocyte ratio and lactate
dehydrogenase levels in metastatic colorectal cancer. Oncologist.
25:661–668. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Partl R, Paal K, Stranz B, Hassler E,
Magyar M, Brunner TB and Langsenlehner T: The pre-treatment
platelet-to-lymphocyte ratio as a prognostic factor for
loco-regional control in locally advanced rectal cancer.
Diagnostics (Basel). 13:6792023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dudani S, Marginean H, Tang PA, Monzon JG,
Raissouni S, Asmis TR, Goodwin RA, Gotfrit J, Cheung WY and Vickers
MM: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as
predictive and prognostic markers in patients with locally advanced
rectal cancer treated with neoadjuvant chemoradiation. BMC Cancer.
19:6642019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamada K, Araki S, Tamura M, Sakai I,
Takahashi Y, Kashihara H and Kono S: Relation of serum total
cholesterol, serum triglycerides and fasting plasma glucose to
colorectal carcinoma in situ. Int J Epidemiol. 27:794–798. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oneyama C, Iino T, Saito K, Suzuki K,
Ogawa A and Okada M: Transforming potential of Src family kinases
is limited by the cholesterol-enriched membrane microdomain. Mol
Cell Biol. 29:6462–6472. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sheng R, Kim H, Lee H, Xin Y, Chen Y, Tian
W, Cui Y, Choi JC, Doh J, Han JK and Cho W: Cholesterol selectively
activates canonical Wnt signalling over non-canonical Wnt
signalling. Nat Commun. 5:43932014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blank N, Schiller M, Gabler C, Kalden JR
and Lorenz HM: Inhibition of sphingolipid synthesis impairs
cellular activation, cytokine production and proliferation in human
lymphocytes. Biochem Pharmacol. 71:126–135. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamaguchi T and Ishimatu T: Effects of
cholesterol on membrane stability of human erythrocytes. Biol Pharm
Bull. 43:1604–1608. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiong S, Dong L and Cheng L: Neutrophils
in cancer carcinogenesis and metastasis. J Hematol Oncol.
14:1732021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khan U, Chowdhury S, Billah MM, Islam KMD,
Thorlacius H and Rahman M: Neutrophil extracellular traps in
colorectal cancer progression and metastasis. Int J Mol Sci.
22:72602021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meng X, Shi D, Zheng H, Xu Y, Li Q, Cai S
and Cai G: High preoperative peripheral blood neutrophil predicts
poor outcome in rectal cancer treated with neoadjunctive
chemoradiation therapy. Int J Clin Exp Pathol. 10:7718–7725.
2017.PubMed/NCBI
|
|
33
|
Rottmann BG, Patel N, Ahmed M, Deng Y,
Ciarleglio M, Vyas M, Jain D and Zhang X: Clinicopathological
significance of neutrophil-rich colorectal carcinoma. J Clin
Pathol. 76:34–39. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schernberg A, Huguet F, Moureau-Zabotto L,
Chargari C, Rivin Del Campo E, Schlienger M, Escande A, Touboul E
and Deutsch E: External validation of leukocytosis and neutrophilia
as a prognostic marker in anal carcinoma treated with definitive
chemoradiation. Radiother Oncol. 124:110–117. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Alsaab HO, Sau S, Alzhrani R, Tatiparti K,
Bhise K, Bhise K, Kashaw SK and Iyer AK: PD-1 and PD-L1 checkpoint
signaling inhibition for cancer immunotherapy: mechanism,
combinations, and clinical outcome. Front Pharmacol. 8:5612017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Paun BC, Cassie S, MacLean AR, Dixon E and
Buie WD: Postoperative complications following surgery for rectal
cancer. Ann Surg. 251:807–818. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mei F, Yang X, Na L and Yang L: Anal
preservation on the psychology and quality of life of low rectal
cancer. J Surg Oncol. 125:484–492. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hiotis SP, Weber SM, Cohen AM, Minsky BD,
Paty PB, Guillem JG, Wagman R, Saltz LB and Wong WD: Assessing the
predictive value of clinical complete response to neoadjuvant
therapy for rectal cancer: An analysis of 488 patients. J Am Coll
Surg. 194:131–136. 2002. View Article : Google Scholar : PubMed/NCBI
|
